Bronstein Ben 4
4 · Aldeyra Therapeutics, Inc. · Filed Jun 9, 2022
Insider Transaction Report
Form 4
Bronstein Ben
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-07+53,812→ 53,812 totalExercise: $3.60Exp: 2032-06-06→ Common Stock (53,812 underlying) - Award
Stock Option (Right to Buy)
2022-06-07+3,711→ 3,711 totalExercise: $3.60Exp: 2032-06-06→ Common Stock (3,711 underlying) - Award
Stock Option (Right to Buy)
2022-06-07+3,479→ 3,479 totalExercise: $3.60Exp: 2032-06-06→ Common Stock (3,479 underlying)
Footnotes (3)
- [F1]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
- [F2]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.
- [F3]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.